GVHD-derived plasma as a priming strategy of mesenchymal stem cells (2020)
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, LINFÓCITOS, DOENÇA ENXERTO-HOSPEDEIRO, ADJUVANTES IMUNOLÓGICOS, IMUNOSSUPRESSÃO
ABNT
SILVA-CARVALHO, Amandda Évelin et al. GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, v. 11, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13287-020-01659-x. Acesso em: 08 out. 2024.APA
Silva-Carvalho, A. É., Rodrigues, L. P., Schiavinato, J. L. dos S., Alborghetti, M. R., Bettarello, G., Simões, B. P., et al. (2020). GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, 11, 1-12. doi:10.1186/s13287-020-01659-xNLM
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 out. 08 ] Available from: https://doi.org/10.1186/s13287-020-01659-xVancouver
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 out. 08 ] Available from: https://doi.org/10.1186/s13287-020-01659-x